NONPROFIT, NONPARTISAN PLATFORM OF ACCURATE SCIENCE-BASED SOLUTIONS TO COVID-19

Zymo Research Corporation

Business Name:
Zymo Research Corporation
Business Genre:
Business Description:

Founded in 1994 in California, Zymo now produces DNA and RNA extraction kits for academic and pharmaceutical labs. Also produce kits for DNA detection and quantitation. Worldwide facilities and sales with >70 large distributors. [2]

City:
Irvine
State:
CA
Country:
USA
Data/Evidence of Effectiveness:
LOD is 5 genomic copies/rxn, or 0.083 genomic copies/uL. Less accurate at high mucin concentrations. Showed no cross-reactivity in vitro with any of the potential bugs from in sillico analysis, except did not test SARS-CoV because it’s not circulating. [4]
Complimentary Products Needed to Perform Test:
Kit provides: positive control, master mixes, negative control. Still required:general laboratory equipment, swab and collection kit, RNA extraction, RT-PCR thermocycler [4]
Setting of Care:
H [1]
Current Status / Clinical Development Stage / Expected Milestones:
EUA approved on 5/7/2020, kits are available for sale worldwide [1][4]
Funding & Ownership :
privately owned [3]
Business Model:
Produce and sell DNA/RNA extraction and quantitation kits for academic and biopharmaceutical labs [2]
IP:
all tech is proprietary and trademarked [3]
History & Origins :
Company specializes in infectious disease detection technologies, with products in use in 60+ countries.[3]
Date EUA Issued:
05/07/2020 [1]
Sources:
[1] https://www.fda.gov/medical-devices/emergency-situations-medical-devices/emergency-use-authorizations [2] https://www.zymoresearch.com/pages/about-zymo-research [3] https://www.zymoresearch.com/blogs/press-releases/zymo-research-ceo-to-be-interviewed-on-worldwide-business-with-kathy-ireland#:~:text=LarryJiaFounderandCEO,Dr. [4] https://files.zymoresearch.com/protocols/_r3011-quick_sars-cov-2_rrt-pcr_kit.pdf
Organization:
CEO: Dr. Larry Jia [3]
Time to Result:
2-3 hours (standard RT-PCR time) [4]
Test Sample Type:
nasopharyngeal, mid-turbinate or oropharyngeal swabs, sputum, tracheal aspirates, and bronchoalveolar lavage [4]
Technology Overview:
RT-PCR kit that targets the N gene in SARS-CoV-2 and RNase P gene from humans [4]
Testing Type:
RT-PCR [4]
Test Category:
RT-PCR
Test Name:
Quick SARS-CoV-2rRT-PCR Kit [1]
Clinical Application & Need:
“detect current infection from nasal, nasopharyngeal, mid-turbinate or oropharyngeal swabs, sputum, tracheal aspirates, and bronchoalveolar lavage [4]”

Send Message to listing owner

Leave A Reply